CRISPR THERAPEUTICS AG 2025-2026 Proxy Voting Records

Description as filed by funds: BINDING VOTE ON MAXIMUM EQUITY FOR MEMBERS OF THE BOARD OF DIRECTORS FROM THE 2026 ANNUAL GENERAL MEETING TO THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 52 managers: 7,321,136 for, 1,305,111 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 51 managers: 3,283,860 for, 30,193 against. Showing the 25 largest; see all in the interactive database.

The 77 asset managers below reported 11,106,682 for, 664,822 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

The 73 asset managers below reported 19,676,269 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of the members to the Board of Directors and the Chairman: Re-election of Samarth Kulkarni, Ph.D., as member and Chairman

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Samarth Kulkarni, Ph.D.”): 47,043,987 for, 1,628,226 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 19,375,839 for, 300,475 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Maria Fardis, Ph.D.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Maria Fardis, Ph.D.”): 47,804,457 for, 874,207 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 19,477,676 for, 198,637 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Simeon J. George, M.D.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Simeon J. George, M.D.”): 47,435,748 for, 1,225,519 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 19,455,052 for, 221,262 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Katherine A. High, M.D.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Katherine A. High, M.D.”): 47,779,619 for, 899,787 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 19,471,816 for, 204,498 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Sandesh Mahatme, LL.M.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Sandesh Mahatme, LL.M.”): 46,268,964 for, 2,405,580 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 18,847,181 for, 829,133 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Christian Rommel, Ph.D.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Christian Rommel, Ph.D.”): 47,802,202 for, 872,050 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 19,479,291 for, 197,023 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Re-election of Douglas A. Treco, Ph.D.

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Douglas A. Treco, Ph.D.”): 44,359,453 for, 4,317,384 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 18,251,923 for, 1,424,390 against.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

The 72 asset managers below reported 19,676,244 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 17 managers: 705,516 for.

Institutional-manager reports, all 51 managers: 3,321,627 for. Showing the 25 largest; see all in the interactive database.

The 57 asset managers below reported 8,290,485 for, 904,097 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

The 56 asset managers below reported 5,806,524 for, 2,821,483 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

The 56 asset managers below reported 8,282,304 for, 904,129 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

The 55 asset managers below reported 8,022,929 for, 605,008 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

The 41 asset managers below reported 5,771,944 for, 2,148,787 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

The 35 asset managers below reported 10,041,772 for, 1,691,297 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

The 25 asset managers below reported 10,996,916 for, 109,398 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

The 25 asset managers below reported 10,998,530 for, 107,784 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

The 72 asset managers below reported 19,672,682 for, 3,562 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

The 72 asset managers below reported 19,416,938 for, 259,306 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2025.

The 73 asset managers below reported 19,676,269 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

The 73 asset managers below reported 19,676,269 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Description as filed by funds: Transact any other business that may properly come before the 2026 Annual General Meeting or any adjournment or postponement thereof.

The 72 asset managers below reported 15,559,697 for, 4,116,546 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: BINDING VOTE ON MAXIMUM VARIABLE COMPENSATION FOR MEMBERS OF THE EXECUTIVE COMMITTEE FOR THE CURRENT YEAR ENDING DECEMBER 31, 2026.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 52 managers: 8,197,690 for, 428,557 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 50 managers: 3,307,943 for, 10 against. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 68 managers: 19,418,451 for, 255,753 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 12 managers: 1,069,818 for, 10 against.

Description as filed by funds: NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS UNDER U.S. SECURITIES LAW REQUIREMENTS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 69 managers: 13,055,643 for, 6,620,881 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 427 managers: 8,374,140 for, 12,235,258 against, 1,251 abstained, 39,413 not voted. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 52 managers: 7,506,432 for, 1,119,815 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 72 managers: 3,302,940 for, 9,569 against, 1,173 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 52 managers: 8,197,690 for, 428,557 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 50 managers: 3,307,643 for, 310 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: BINDING VOTE ON MAXIMUM EQUITY FOR MEMBERS OF THE EXECUTIVE COMMITTEE FROM THE 2026 ANNUAL GENERAL MEETING TO THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.